Biostage, Inc. filed its 10-K on Mar 30, 2023 for the period ending Dec 31, 2022. In this report its auditor, Marcum LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Harvard Apparatus Regenerative Technology Inc.
Equities
HRGN
US09074M2026
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.39 USD | +3.02% | +3.02% | -52.10% |
1st Jan change | Capi. | |
---|---|---|
-52.10% | 34.21M | |
+7.15% | 217B | |
+6.60% | 183B | |
+9.86% | 131B | |
+24.32% | 106B | |
-0.95% | 62.16B | |
+11.04% | 51.02B | |
+4.81% | 50.89B | |
-1.43% | 40.16B | |
+24.40% | 31.44B |
- Stock Market
- Equities
- HRGN Stock
- News Harvard Apparatus Regenerative Technology Inc.
- Biostage, Inc. Auditor Raises 'Going Concern' Doubt